Oral hypoglycemic agents? Negative.
I am convinced that oral hypoglycemic therapy is associated with increased cardiovascular mortality. But the more important issue is whether the benefits of these agents are worth the risk.
Harvard School of Public Health, Veterans Affairs Medical Center, Boston.
T C
TC
Chalmers
D001291:Attitude of Health Personnel; D015982:Bias; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D010820:Physicians / Q000523:psychology; D012106:Research / Q000592:standards*
D007004:Hypoglycemic Agents; D007328:Insulin